首页> 外文期刊>Knowledge Technology & Policy >Between Minimal and Greater Than Minimal Risk: How Research Participants and Oncologists Assess Data-Sharing and the Risk of Re-identification in Genomic Research
【24h】

Between Minimal and Greater Than Minimal Risk: How Research Participants and Oncologists Assess Data-Sharing and the Risk of Re-identification in Genomic Research

机译:在最小风险与大于最小风险之间:研究参与者和肿瘤学家如何评估数据共享和基因组研究中重新识别的风险

获取原文
获取原文并翻译 | 示例
           

摘要

Data-sharing among genomic researchers is promoted for its potential to accelerate our understanding of the molecular basis of cancer. However, with genomic data sharing the risks of re-identifying study participants, revealing personal genomic information and data misuse might increase. This study aims at exploring perceptions of patients and physicians in Oncology regarding their assessment of the informational risks resulting from participating in whole genomic research studies in order to improve the informed consent process. For this purpose, we conducted a qualitative focus group study at the National Center for Tumor Diseases (NCT). Patients and oncologists assessed the informational risks either as minimal or as greater than minimal, depending on the context factors of occupational status, age, and patients' prognosis. Interestingly, even patients who assumed a greater risk did not refrain from participating in genomic research, provided that certain informational and institutional safeguards are implemented. Moreover, they expected comprehensive disclosure of the risks resulting from genomic data sharing. These results suggest (1) comprehensive disclosure of the risks of genomic research to potential study participants in genomic research to facilitate risk assessment and sound decision making, (2) establishing independent governance entities in order to minimize the informational risks of genomic research, and (3) implementing data sharing policies which offer guidance for physicians and researchers involved in genomic research.
机译:基因组研究人员之间的数据共享得到了促进,因为它有可能促进我们对癌症分子基础的理解。但是,随着基因组数据的共享,重新确定研究参与者的风险,揭示个人基因组信息和数据滥用可能会增加。这项研究旨在探讨患者和医师在肿瘤学中对他们因参与整个基因组研究而产生的信息风险的评估的看法,以改善知情同意程序。为此,我们在国家肿瘤疾病中心(NCT)进行了定性焦点小组研究。患者和肿瘤科医生根据职业状况,年龄和患者预后的背景因素,评估信息风险为最小风险还是大于最小风险。有趣的是,只要实施了某些信息和制度保障措施,即使是承担更大风险的患者也不会参与基因组研究。此外,他们期望全面披露基因组数据共享所带来的风险。这些结果表明(1)向基因组研究的潜在研究参与者全面披露基因组研究的风险,以促进风险评估和合理的决策;(2)建立独立的治理实体,以最大程度地降低基因组研究的信息风险;以及( 3)实施数据共享政策,为参与基因组研究的医师和研究人员提供指导。

著录项

  • 来源
    《Knowledge Technology & Policy》 |2019年第1期|39-55|共17页
  • 作者单位

    Department of Nursing Science, University of Philosophy and Theology, Pallottistrasse 3, 56179 Vallendar, Germany;

    Department of Medical Oncology, Programme for Ethics and Patient-Oriented Care in Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany;

    Department of Population Health Sciences, School of Medicine, University of Utah, Williams Building, 295 Chipeta Way, Salt Lake City, UT 84108, USA;

    Department of Medical Oncology, Programme for Ethics and Patient-Oriented Care in Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany;

    Department of Translational Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany,Heidelberg Center for Personalized Oncology, DKFZ-HIPO, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120 Heidelberg, Germany;

    Department of Medical Oncology, Programme for Ethics and Patient-Oriented Care in Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Genomic research; Data sharing; Risk of re-identification; Data misuse; Risk assessment; Policy making;

    机译:基因组研究;数据共享;重新识别的风险;数据滥用;风险评估;政策制作;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号